IMS HEALTH INCORPORATED (NY:RX)
21.38
-0 (-0%)
| IMS HEALTH INCORPORATED (NY:RX) Delayed : |
| Previous Close |
$21.38 |
|
52 Week High |
$21.68 |
|
| Open |
$21.30 |
|
52 Week Low |
$11.12 |
| Day High |
$21.38 |
|
P/E |
13.71 |
| Day Low |
$21.38 |
|
EPS |
$1.56 |
| Volume |
4,219,471 |
|
|
|
| More RX Info:
Chart
SEC Filings
Profile
Historical
Options
|
IMS Health Inc. Summary
IMS Health Incorporated provides information solutions to the pharmaceutical and healthcare industries worldwide. It offers sales territory reporting services for various applications, prescription tracking reporting services, sales and account management, and other consulting and services. The company also offers brand management, promotional audit, forecasting portfolio, and launch management services, as well as managed care and consumer health ...more
Executives
David R. Carlucci - Chairman, CEO, & President
Links
http://www.imshealth.com
-
Nov 19, 2009 01:15 PM
Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low
-
Nov 6, 2009 04:35 PM
Top 10 News Items 11/02-11/06: Unemployment Rate Now Over 10%, Fed to Keep Rates 'Exceptionally Low' for 'Extended Period', Buffett Does the Biggest Deal of His Life
-
Nov 5, 2009 12:43 PM
Unusual 11 Mid-Day Movers 11/05: RX, FSYS, NWK, ROYL Higher; SMSI, ELMG, PL, CVS Lower
-
Nov 5, 2009 10:52 AM
Morning Movers 11/05: ROYL, RX, FSYS, KAI, SANM Higher; SMSI, CVS, MBRK, INOD, PL, ARO Lower
-
Nov 5, 2009 10:48 AM
Notable Mergers and Acquisitions of the Day 11/5: AGU/CF, SNI, RX
View All Reports
-
Nov 26, 2009 04:07PM
BioSyent Releases 2009 Third Quarter Financial Results
-
Nov 26, 2009 04:06PM
BioSyent Releases 2009 Third Quarter Financial Results
-
Nov 11, 2009 10:14AM
IMS Health to Launch Oncology Quantifier, Delivering Integrated Insights for Enhanced Market Measurement, Commercial Strategies
-
Nov 6, 2009 06:30PM
Law Offices of Brian M. Felgoise, P.C. Announces Investigation on Behalf of Shareholders of IMS Health, Inc.
-
Nov 6, 2009 04:30PM
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of IMS Health, Inc.
View All Press Releases
StreetInsider Reports on RX by Category
Comments on RX
No comments are currently available.